Symptom | Univariate regression | Standardised for GNP | |||||
---|---|---|---|---|---|---|---|
Coefficient | Standard error | p value | Coefficient | Standard error | p value | ||
Written asthma questionnaire | |||||||
Wheeze ever | −0.284 | 0.062 | <0.001 | −0.187 | 0.081 | 0.024 | |
Wheeze in last 12 months | −0.164 | 0.043 | <0.001 | −0.052 | 0.055 | 0.344 | |
Asthma ever | −0.198 | 0.028 | <0.001 | −0.131 | 0.036 | 0.001 | |
Video asthma questionnaire | |||||||
Wheeze at rest in last 12 months | −0.135 | 0.030 | <0.001 | −0.091 | 0.037 | 0.018 | |
Rhinitis questionnaire | |||||||
Rhinitis ever | −0.324 | 0.054 | <0.001 | −0.119 | 0.063 | 0.062 | |
Rhinitis in last 12 months | −0.275 | 0.049 | <0.001 | −0.083 | 0.057 | 0.148 | |
Rhinitis with itchy/watery eyes in last 12 months | −0.168 | 0.025 | <0.001 | −0.073 | 0.029 | 0.015 | |
Eczema questionnaire | |||||||
Itchy rash ever | −0.083 | 0.038 | 0.029 | 0.050 | 0.042 | 0.244 | |
Itchy rash in last 12 months | −0.082 | 0.031 | 0.010 | 0.022 | 0.035 | 0.544 | |
Eczema ever | −0.094 | 0.047 | 0.048 | 0.061 | 0.056 | 0.278 |
↵1-150 Europe, USA, Canada, Australia, New Zealand.